Biotech News
Related news
BLTEBelite Bio2026-05-20 10:00 EST
Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
BLTEBelite Bio2026-05-13 20:00 EST
Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
ALTAltimmune2026-05-13 11:30 EST
Altimmune Announces First Quarter 2026 Financial Results and Business Update
MISTMilestone Pharmaceuticals Inc.2026-05-13 11:11 EST
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
SGMTSagimet Biosciences2026-05-12 11:30 EST
Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
CVRXCVRx2026-05-11 20:05 EST
CVRx Reports First Quarter 2026 Financial and Operating Results
ALGSAligos Therapeutics2026-05-07 20:06 EST
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
LXRXLexicon Pharmaceuticals2026-05-07 11:30 EST
Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates
NAMSNewAmsterdam Pharma2026-05-07 11:00 EST
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
MLYSMineralys Therapeutics2026-05-06 20:05 EST
Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Synlogic
Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.
Recent company news
SYBXSynlogic2026-07-29 11:00 EST
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement
SYBXSynlogic2024-11-12 21:35 EST
Synlogic Reports Third Quarter 2024 Financial Results
SYBXSynlogic2024-08-08 11:00 EST
Synlogic Reports Second Quarter 2024 Financial Results
SYBXSynlogic2024-05-14 11:00 EST
Synlogic Reports First Quarter 2024 Financial Results
SYBXSynlogic2024-03-19 11:00 EST
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
Stock data
- Close
- 1.20 USD
- Market cap
- —
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States